James Condulis
Stock Analyst at Stifel
(1.73)
# 3,670
Out of 5,182 analysts
13
Total ratings
54.55%
Success rate
-2.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Condulis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Maintains: Buy | $125 → $130 | $96.53 | +34.67% | 1 | Apr 29, 2026 | |
| TECX Tectonic Therapeutic | Initiates: Buy | $75 | $29.03 | +158.40% | 1 | Apr 14, 2026 | |
| AMLX Amylyx Pharmaceuticals | Initiates: Buy | $21 | $16.01 | +31.17% | 1 | Mar 3, 2026 | |
| AARD Aardvark Therapeutics | Downgrades: Hold | $24 → $6 | $5.46 | +9.89% | 2 | Mar 2, 2026 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Buy | $44 → $50 | $28.43 | +75.87% | 2 | Dec 16, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $7.5 → $10 | $4.19 | +138.66% | 1 | Dec 5, 2025 | |
| CYTK Cytokinetics | Maintains: Buy | $87 → $96 | $63.35 | +51.54% | 2 | Sep 2, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $74 → $108 | $52.87 | +104.27% | 2 | Mar 28, 2025 | |
| EWTX Edgewise Therapeutics | Initiates: Hold | $30 | $30.61 | -1.99% | 1 | Jan 22, 2025 |
Mirum Pharmaceuticals
Apr 29, 2026
Maintains: Buy
Price Target: $125 → $130
Current: $96.53
Upside: +34.67%
Tectonic Therapeutic
Apr 14, 2026
Initiates: Buy
Price Target: $75
Current: $29.03
Upside: +158.40%
Amylyx Pharmaceuticals
Mar 3, 2026
Initiates: Buy
Price Target: $21
Current: $16.01
Upside: +31.17%
Aardvark Therapeutics
Mar 2, 2026
Downgrades: Hold
Price Target: $24 → $6
Current: $5.46
Upside: +9.89%
NewAmsterdam Pharma Company
Dec 16, 2025
Maintains: Buy
Price Target: $44 → $50
Current: $28.43
Upside: +75.87%
X4 Pharmaceuticals
Dec 5, 2025
Maintains: Buy
Price Target: $7.5 → $10
Current: $4.19
Upside: +138.66%
Cytokinetics
Sep 2, 2025
Maintains: Buy
Price Target: $87 → $96
Current: $63.35
Upside: +51.54%
Soleno Therapeutics
Mar 28, 2025
Maintains: Buy
Price Target: $74 → $108
Current: $52.87
Upside: +104.27%
Edgewise Therapeutics
Jan 22, 2025
Initiates: Hold
Price Target: $30
Current: $30.61
Upside: -1.99%